Dalip Sethi, Ph.D., MBA, MSc

Commercial Leader, Cell Therapy Technologies, North America, at Terumo Blood and Cell Technologies

As an innovative and transformational leader, Dalip Sethi currently serves as the commercial lead for Terumo BCT's Cell Therapy Technologies portfolio in North America. He holds a doctorate and conducted post-doctoral studies at Thomas Jefferson University, School of Medicine. Throughout his career in academia and industry, Sethi has been engaged in developing technologies and methods for use in cell therapy applications. He has authored multiple scientific publications and is a co-inventor on several patents and patent applications. Sethi is passionate about mentoring and workforce development. He is a CBSA board member. In addition, Sethi is also an ISCT member and participates in committees focused on cold chain, particulates, and process analytical technologies.

1:45-2:45 p.m.

Thursday October 31,  2024

EY’s Pulse of the Industry—Presentation and Panel Discussion

A comprehensive look at the EY report’s findings with a focus on the trends driving change within the industry. From digital healthcare to regulatory shifts, this overview of the happenings within medtech will help shape expectations of what’s ahead for the sector. Following the presentation, a panel will focus on the points highlighted during the presentation and discuss their impact on the medtech sector. Using the report’s findings as the conversation pathway, this group of industry representatives will reflect on how factors such as digital health and regulatory changes, along with numerous other variables, will play a role in shaping healthcare technology.

Presented and moderated by Mark Ginestro.